** Shares of medical product maker Bioventus BVS.O soar 23.5% to $10.82
** Q4 total revenue rises 13.5% to $153.6 million from a year ago, beating analysts' estimate of $145.2 million - data compiled by LSEG
** Co reports quarterly adjusted EPS of 15 cents per share vs estimate of 8 cents per share
** Including session's move, stock is up 1.4% YTD
(Reporting by Jaiveer Singh Shekhawat in Bengaluru)
((JaiveerSingh.Shekhawat@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。